Notify me when ET AL Phillip Frost MD files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OPK | OPKO HEALTH, INC. | Common Stock, par value $0.01 per share | 33% | $351,509,324 | +$674,150 | 252,884,406 | +0.19% | FROST PHILLIP MD ET AL | 30 Sep 2025 |
| FLNT | Fluent, Inc. | Common Stock, par value $0.0005 per share | 25% | $18,897,998 | +$1,371,430 | 7,874,166 | +7.8% | Phillip Frost, M.D. | 22 Dec 2025 |
| COCP | Cocrystal Pharma, Inc. | Common Stock, par value $0.001 per share | 18% | $3,078,992 | +$1,349,571 | 2,462,012 | +78% | Phillip Frost, M.D. | 28 Oct 2025 |
| NNUP | NOCOPI TECHNOLOGIES INC/MD/ | Common stock of the Company, par value $0.01 per share ("Common Shares") | 14% | 1,467,782 | Phillip Frost, M.D. | 06 Jun 2025 | |||
| DOUG | Douglas Elliman Inc. | Common Stock, par value $0.01 per share | 8.6% | $12,700,026 | 7,650,618 | Phillip Frost, M.D. | 01 Jan 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|